The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global patient portal market reached a value of US$ 2905.8 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 6546.8 Million by 2027, exhibiting at a CAGR of 14.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A patient portal is an online service that is generally used by individuals for healthcare assistance. It includes online applications and websites that allow patients to communicate and interact with healthcare professionals. It offers numerous information related to medical records, discharge summaries, doctor visits, medications, and laboratory results of the patient. Along with this, it also facilitates accessible medical help to individuals living in remote and geographically extended locations. As a result, its deployment facilitates better and quick communication with patients while streamlining various processes in an efficient manner.
The global market is primarily driven by rapid digitization across the healthcare sector. Along with this, continual technological advancements across the industry are creating a positive outlook for the market. For instance, the widespread integration of artificial intelligence (AI), cloud-based solutions and big data analytics with patient portals help experts in making quick diagnosis and treatment planning. Additionally, the sudden outbreak of coronavirus (COVID-19) across the globe has also led to the rising need for effective healthcare assistance solutions. Moreover, increasing funding and investments by private and public agencies across the globe to improve the existing healthcare infrastructure is providing an impetus to the market growth. The market is further driven by the rising geriatric population, which is more susceptible to developing medical ailments. Some of the other factors contributing to the market growth include the growing prevalence of chronic illnesses among individuals and the increasing healthcare expenditure.
IMARC Group provides an analysis of the key trends in each sub-segment of the global patient portal market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on portal, deployment mode and end user.
Breakup by Portal:
Breakup by Deployment Mode:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc., Bridge Patient Portal Inc., Cerner Corporation, Chetu Inc., CureMD Healthcare, Eclinicalworks LLC, General Electric Company, Greenway Health LLC, Intelichart LLC, McKesson Corporation and Nextgen Healthcare Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Portal, Deployment Mode, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allscripts Healthcare Solutions Inc., Athenahealth Inc., Bridge Patient Portal Inc., Cerner Corporation, Chetu Inc., CureMD Healthcare, Eclinicalworks LLC, General Electric Company, Greenway Health LLC, Intelichart LLC, McKesson Corporation and Nextgen Healthcare Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at